As of May 31, 2026, the Democratic Republic of Congo has logged more than 1,000 suspected Ebola cases and at least 246 deaths, according to BBC News. This marks a sharp increase from two weeks ago when the outbreak was first declared.

Neighboring Uganda now has nine confirmed cases and one death, according to BBC News. The virus has crossed DRC's borders.

WHO Director Arrives in DRC

WHO Director-General Dr. Tedros Adhanom Ghebreyesus flew to Bunia, the provincial capital of Ituri — the epicenter of the outbreak — on Saturday, according to Doctors Without Borders (MSF).

Tedros said he was there "to see how the response is running and if there are challenges to help," according to BBC News. He urged local communities to take a bigger role in fighting the disease, saying they "understand the problems better and they know the solution as well."

He also issued a direct warning about funeral practices. "Certain practices including touching of bodies of those who have died from Ebola can spread the virus further," Tedros said, as reported by BBC News. "While we grieve for those we've lost, we must do everything we can so that we don't lose another."

AP News reported that five patients have recovered and a new treatment center has opened.

MSF: Response Is Inadequate

MSF Deputy Director of Operations Dr. Alan Gonzalez was direct in his assessment.

"Never before has an Ebola outbreak recorded so many cases so soon after its declaration," Gonzalez said in an official MSF statement dated May 30, 2026. "Like everyone in the affected areas, MSF teams are witnessing a response that has not yet caught up to the rapid spread of the epidemic."

He continued: "The number of expert medical organizations responding on the ground is still far too limited, and the level of support being provided — including our own — falls far short of what is needed."

MSF was acknowledging that its own effort is insufficient. The candor is notable from an organization that rarely criticizes itself publicly.

The Bundibugyo Strain Has No Vaccine

This is the Bundibugyo strain of Ebola, not the more commonly reported Zaire strain.

According to MSF's official statement, the Bundibugyo virus has no approved vaccines and no specific treatments. It is "particularly difficult to diagnose due to limited testing capacity." Hundreds of collected samples remain untested.

Most mainstream coverage describes this as an "Ebola outbreak" without specifying the strain. The Bundibugyo variant is harder to contain than previous outbreaks where vaccines were available and deployable.

Border Closures Are Hampering Supply Lines

MSF's Gonzalez flagged "major constraints, including border and airport closures" as delaying critical medical supplies, humanitarian aid, and specialized personnel — according to the MSF statement.

"We know from experience that these measures severely hinder outbreak response, and isolate countries that urgently need international support," Gonzalez said.

Border closures are a standard disease control tool. They also restrict the supply chains needed to fight disease spread.

Ongoing armed conflict in eastern DRC compounds these problems, according to WHO warnings cited by BBC News. Sending medical teams into an active conflict zone is dangerous. Not sending them means the virus spreads unchecked.

Deeper Questions

Most outlets frame this as a humanitarian crisis requiring more international aid. That is accurate.

But after multiple DRC Ebola outbreaks over the past decade, questions remain about why testing infrastructure is still this weak and why treatment centers are still being opened two weeks into what MSF calls the fastest-growing outbreak on record. The WHO managed similar outbreaks in 2018, 2019, and 2020 in DRC. Those experiences raised questions about whether surge capacity should have been pre-positioned and ready for future outbreaks.

Current Situation

Five recoveries and a new treatment center are positive developments. Tedros's presence signals international attention.

But 1,000 suspected cases in two weeks, an untestable backlog of samples, a strain with no vaccine, and supply lines choked by border closures remain the facts on the ground. The gap between available resources and what is needed remains substantial. Until that closes, case numbers are likely to continue climbing.